Objective: To determine the socio-demographic profiles and some clinical aspects of patients with rheumatoid arthritis (RA). Design: Prospective, cross-sectional study. Setting: Ambulatory outpatient clinics of Kenyatta National Hospital (KNH), a public national and referral hospital. Subjects: Out of 180 patients interviewed and examined, 60 met American College of Rheumatology (ACR) diagnostic criteria of RA. Results: Of the 60 patients recruited 52 (87%) were females with male: female ratio of 1: 6.5. The mean age of patients was 41.38(± 16.8) years. There were two peaks of age of occurrence, 20-29 and 40-49 years. In 75% of the study patients, one or more of metacarpophalangeal joints of the hand were involved in the disease. Other frequently involved sites were-wrists, elbows, knees, ankles and glenohumeral joints of shoulders in a symmetrical manner. Serum rheumatoid factor was positive in 78.9% while rheumatoid nodules were present in 13.3% of the study patients. A large majority of patients (88%) had active disease with 18% having mild disease, 38% moderate activity and 32% having severe disease. Only 12% of patients had disease in remission. Forty six point seven per cent (46.7%) of the study patients were on at least one Disease Modifying anti Rheumatic Drugs (DMARD) from a selection of methotrexate, sulphasalazine, hydroxychloroquine and leflunamide. The most frequent drug combination was methotrexate plus prednisolone at 30% of the study population; while 66.7% were on oral prednisolone with 25% of the study patients taking only Non-Steroidal anti Inflammatory Drugs (NSAIDS). Conclusion: A large majority of ambulatory patients with RA had active disease. Most of' them were sub-optimally treated, especially the use of DMARDS. About two thirds were on oral steroids. Sub-optimal therapy in relatively young patients, peak 20-29 and 40-49 years is likely to impact negatively on their disease control and quality of life.
Objective: To determine Health Related Quality Of Life (HRQOL) profiles of patients with Rheumatoid Arthritis (RA).Design: Prospective, cross-sectional study. Setting: Ambulatory out-patient clinics of Kenyatta National Hospital (KNH), a public national referral hospital. Subjects: Of the 180 patients interviewed and examined, 60 met the American College of Rheumatology (ACR) diagnostic criteria for RA. Results: Of the 60 patients recruited, 58% of study patients had physical component HRQOL scores ranging from poor to fair, compared to 65% who had mental component HRQOL scores ranging from good to very good. Both physical and mental health HRQOL summary scores showed significant negative correlations with disease activity (DAS-28) scores (p< 0.001 for both) among the study patients. The HRQOL physical health summary scores were significantly better in the 28 study patients who were on treatment with at least one DMARD (mean score 67.25 ± 18.17) than in the other 28 study patients who had not been on DMARD therapy (mean score 53.93 ± 18.55), p = 0.008. The trend was similar but less prominent with mental health QOL summary scores, with means of 75.11 ± 19.19 with DMARDs, and 62.29 ± 21.85 without DMARDs (p = 0.034). There was a significant association between consistency of treatment with any drug and QOL physical health summary scores, with mean score for patients consistently on treatment (65.16 ± 19.26) being much better than for those on intermittent drug treatment (50.94 ± 16.27), p = 0.009. These associations were similar for QOL mental health summary scores but did not reach significance. Conclusions: In this population of ambulatory patients with RA, physical component HRQOL ranged from poor to fair, while mental component HRQOL ranged from good to very good in the majority of patients. Severity of disease showed a strong negative association with HRQOL among the study patients, while DMARD therapy and adherence to drug treatment showed a positive association with HRQOL. Improved and better adherence to DMARD therapy with resultant decrease in disease activity is likely to result in improved HRQOL in this population of patients with RA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.